Person

Margaret G. McGlynn

Formerly Director, Vertex Pharmaceuticals

Current S&P 500 boards
0
Current roles
0
Open-market buys
$0
Open-market sales
$14.5M

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

No current S&P 500 role.

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

Sits alongside

People who currently share a board or management team with this person.

No current colleagues on record.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
Apr 8, 2022VRTXSale4,900$280.19$1.4M
Apr 8, 2022VRTXSale100$281.49$28K
Mar 31, 2022VRTXSale1,011$262.97$266K
Mar 31, 2022VRTXSale2,970$262.37$779K
Mar 31, 2022VRTXSale1,019$261.28$266K
Jan 28, 2022VRTXSale800$241.83$193K
Jan 28, 2022VRTXSale212$243.24$52K
Jan 28, 2022VRTXSale2,087$242.78$507K
Jan 28, 2022VRTXSale1,901$240.53$457K
Oct 22, 2019VRTXSale20,000$190.00$3.8M
Aug 13, 2019VRTXSale10,000$185.00$1.9M
Mar 2, 2018VRTXSale10,000$170.00$1.7M
Jan 23, 2018VRTXSale10,000$165.00$1.6M
Jan 22, 2018VRTXSale10,000$160.00$1.6M

SEC reporting-owner ID (CIK) 1215126 · all filings on EDGAR

Margaret G. McGlynn | USBoard